Evotec FY20 Adj. EBITDA Declines - Quick Facts

Evotec SE (EVTCY.PK,EVOTF.PK) reported financial 2020 net income of 6.3 million euros compared to 37.2 million euros, prior year. Earnings per Evotec share was 0.04 euros compared to 0.25 euros. Adjusted group EBITDA declined to 106.6 million euros from 123.1 million euros, which corresponds to an adjusted EBITDA margin of 21.3% compared to 27.6%.

Fiscal year 2020 revenues from contracts with customers rose significantly by 12% year-on-year to 500.9 million euros. Excluding material costs, revenues were 479.1 million euros.

For 2021, the company projects: revenues to be in a range of 550 million euros to 570 million euros; and adjusted EBITDA to be in the range of 105 million euros to 120 million euros.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Southwest Airlines' flights across the United States were delayed for hours on Monday evening due to technical issue in a weather information system by a third-party weather data provider. The airline later resumed flight operations after solving the issue, but there were delays. The United Kingdom's Competition and Markets Authority or CMA announced Tuesday that it has launched a market study into mobile ecosystems of technology giants Apple Inc. (AAPL) and Google, Inc. (GOOG) over concerns they have market power which is harming users and other businesses. The CMA is taking... Eli Lilly and Co. (LLY) announced Tuesday that it will conduct a head-to-head study comparing once-monthly injectable Emgality (galcanezumab-gnlm) with Nurtec ODT (rimegepant), an orally disintegrating tablet patients take every other day. This study will help to advance the science of migraine treatment...
Follow RTT